Heuking Kühn Lüer Wojtek advised WuXi Biologics on this transaction. Globally operating Chinese group WuXi Biologics completed the acquisition of a drug substance facility from Bayer...
WuXi Biologics’ Acquisition of Bayer Biologics And COVID-19 Vaccines Facility
WuXi Biologics’ Acquisition of Bayer Biologics And COVID-19 Vaccines Facility
Heuking Kühn Lüer Wojtek advised WuXi Biologics on this transaction. Globally operating Chinese group WuXi Biologics completed the acquisition of a drug substance facility from Bayer...